» Articles » PMID: 37539749

Expression Pattern of Nicotinic Acetylcholine Receptor Subunit Transcripts in Neurons and Astrocytes in the Ventral Tegmental Area and Locus Coeruleus

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2023 Aug 4
PMID 37539749
Authors
Affiliations
Soon will be listed here.
Abstract

Acetylcholine is the endogenous agonist for the neuronal nicotinic acetylcholine receptor (nAChR) system, which is involved in attention, memory, affective behaviours and substance use disorders. Brain nAChRs are highly diverse with 11 different subunits that can form multiple receptor subtypes, each with distinct receptor and pharmacological properties. Different neuronal cell types can also express different nAChR subtypes, resulting in highly complex cholinergic signalling. Identifying which nAChR subunit transcripts are expressed in cell types can provide an indication of which nAChR combinations are possible and which receptor subtypes may be most pharmacologically relevant to target. In addition to differences in expression across cell types, nAChRs also undergo changes in expression levels from adolescence to adulthood. In this study, we used fluorescent in situ hybridization to identify and quantify the expression of α4, α5, α6, β2 and β3 nAChR subunit transcripts in dopaminergic, GABAergic, glutamatergic and noradrenergic neurons and astrocytes in the ventral tegmental area (VTA) and locus coeruleus (LC) in adult and adolescent, male and female C57BL/6J mice. There were distinct differences in the pattern of nAChR subunit transcript expression between the two brain regions. LC noradrenergic neurons had high prevalence of α6, β2 and β3 expression, with very low expression of α4, suggesting the α6(non-α4)β2β3 receptor as a main subtype in these neurons. VTA astrocytes from adult mice showed greater prevalence of α5, α6, β2 and β3 transcript compared with adolescent mice. These data highlight the complex nAChR expression patterns across brain region and cell type.

Citing Articles

Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease.

Soares E, Costa A, Ferrolho G, Ureshino R, Getachew B, Costa S Cells. 2024; 13(6.

PMID: 38534318 PMC: 10969434. DOI: 10.3390/cells13060474.


Subregion and sex differences in ethanol activation of cholinergic and glutamatergic cells in the mesopontine tegmentum.

Mulloy S, Aback E, Gao R, Engel S, Pawaskar K, Win C Sci Rep. 2024; 14(1):46.

PMID: 38168499 PMC: 10762073. DOI: 10.1038/s41598-023-50526-1.

References
1.
Renda A, Penty N, Komal P, Nashmi R . Vulnerability to nicotine self-administration in adolescent mice correlates with age-specific expression of α4* nicotinic receptors. Neuropharmacology. 2016; 108:49-59. DOI: 10.1016/j.neuropharm.2016.04.019. View

2.
Poe G, Foote S, Eschenko O, Johansen J, Bouret S, Aston-Jones G . Locus coeruleus: a new look at the blue spot. Nat Rev Neurosci. 2020; 21(11):644-659. PMC: 8991985. DOI: 10.1038/s41583-020-0360-9. View

3.
Spear L . Modeling adolescent development and alcohol use in animals. Alcohol Res Health. 2001; 24(2):115-23. PMC: 6713014. View

4.
Ranjbar-Slamloo Y, Fazlali Z . Dopamine and Noradrenaline in the Brain; Overlapping or Dissociate Functions?. Front Mol Neurosci. 2020; 12:334. PMC: 6986277. DOI: 10.3389/fnmol.2019.00334. View

5.
Xiu J, Nordberg A, Zhang J, Guan Z . Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42). Neurochem Int. 2005; 47(4):281-90. DOI: 10.1016/j.neuint.2005.04.023. View